Haleon plc (NYSE:HLN) Short Interest Update

Haleon plc (NYSE:HLN - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 23,970,000 shares, a decline of 5.5% from the March 31st total of 25,360,000 shares. Approximately 0.5% of the company's shares are sold short. Based on an average trading volume of 5,710,000 shares, the days-to-cover ratio is presently 4.2 days.

Analysts Set New Price Targets

HLN has been the subject of several research reports. Argus reaffirmed a "buy" rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC started coverage on Haleon in a research report on Wednesday, April 17th. They set a "buy" rating for the company. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy".

Haleon Stock Up 0.7 %

HLN traded up $0.06 on Tuesday, reaching $8.53. The company's stock had a trading volume of 6,439,016 shares, compared to its average volume of 5,371,523. The stock has a 50 day moving average of $8.33 and a two-hundred day moving average of $8.29. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $38.95 billion, a price-to-earnings ratio of 30.50, a P/E/G ratio of 2.21 and a beta of 0.29. Haleon has a fifty-two week low of $7.70 and a fifty-two week high of $8.98.

Haleon Dividend Announcement

The firm also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be issued a $0.1064 dividend. This represents a yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon's dividend payout ratio (DPR) is 75.00%.

Hedge Funds Weigh In On Haleon

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Hexagon Capital Partners LLC lifted its stake in Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company's stock valued at $35,000 after buying an additional 2,193 shares during the last quarter. Pinnacle Bancorp Inc. lifted its stake in Haleon by 853.4% in the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company's stock valued at $39,000 after buying an additional 4,267 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in Haleon in the first quarter valued at approximately $43,000. Tower Research Capital LLC TRC lifted its stake in Haleon by 146.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company's stock valued at $44,000 after buying an additional 3,211 shares during the last quarter. Finally, SRS Capital Advisors Inc. lifted its stake in Haleon by 456.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company's stock valued at $45,000 after buying an additional 4,477 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.